加速康复外科对微创食管切除术影响的随机对照试验
ERAS组术后总并发症率和肺部并发症率更低,下床活动更早,但吻合口漏发生率和住院时间无差异。
要点
- ERAS方案可降低微创食管切除术后总并发症和肺部并发症。
- ERAS组下床活动更早,但住院时间未缩短。
- 吻合口漏发生率两组相当,仍需针对性优化。
核心结论
- 对微创食管切除术患者实施ERAS方案可促进早期下床活动并降低肺部并发症,但不改变吻合口漏发生率或住院时间。
研究设计与样本
- 随机对照试验,2016年3月至2018年8月连续纳入接受三阶段微创食管切除术的食管癌患者,随机分为ERAS+组(60例)和ERAS-组(58例)。
主要发现
- ERAS+组术后总并发症率33.3% vs. 51.7%(p=0.04),肺部并发症率16.7% vs. 32.8%(p=0.04)。
- 吻合口漏发生率11.7% vs. 15.5%(p=0.54),两组相当。
- ERAS+组下床活动时间3[2-3]天 vs. 3[3-4]天(p=0.001),更早。
- 住院时间10[9-11.25]天 vs. 10[9-13]天(p=0.165),无差异。
- SAS评分7.80±1.03 vs. 8.07±0.89(p=0.21),VAS评分1.74±0.85 vs. 1.78±1.06(p=0.84),均无差异。
临床怎么用
- 对微创食管切除术患者可实施基于指南的ERAS方案以降低总并发症和肺部并发症并促进早期活动。
- ERAS方案未显示缩短住院时间或降低吻合口漏,需继续关注吻合口漏的预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this randomized controlled trial was to determine if enhanced recovery after surgery (ERAS) would improve outcomes for three-stage minimally invasive esophagectomy (MIE). METHODS: Patients with esophageal cancer undergoing MIE between March 2016 and August 2018 were consecutively enrolled, and were randomly divided into 2 groups: ERAS+group that received a guideline-based ERAS protocol, and ERAS- group that received standard care. The primary endpoint was morbidity after MIE. The secondary endpoints were the length of stay (LOS) and time to ambulation after the surgery. The perioperative results including the Surgical Apgar Score (SAS) and Visualized Analgesia Score (VAS) were also collected and compared. RESULTS: A total of 60 patients in the ERAS+ group and 58 patients in the ERAS- group were included. Postoperatively, lower morbidity and pulmonary complication rate were recorded in the ERAS+ group (33.3% vs. 51.7%; p = 0.04, 16.7% vs. 32.8%; p = 0.04), while the incidence of anastomotic leakage remained comparable (11.7% vs. 15.5%; p = 0.54). There was an earlier ambulation (3 [2-3] days vs. 3 [3-4] days, p = 0.001), but comparable LOS (10 [9-11.25] days vs. 10 [9-13] days; p = 0.165) recorded in ERAS+ group. The ERAS protocol led to close scores in both SAS (7.80 ± 1.03 vs. 8.07 ± 0.89, p = 0.21) and VAS (1.74 ± 0.85 vs. 1.78 ± 1.06, p = 0.84). CONCLUSIONS: Implementation of an ERAS protocol for patients undergoing MIE resulted in earlier ambulation and lower pulmonary complications, without a change in anastomotic leakage or length of hospital stay. Further studies on minimizing leakage should be addressed in ERAS for MIE.
引用
- Shen Y, Chen X, Hou J, et al. The effect of enhanced recovery after minimally invasive esophagectomy: a randomized controlled trial. Surg Endosc. 2022. PMID: 35773604. doi:10.1007/s00464-022-09385-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。